• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳入减轻严重程度的长期免疫力的模型:在流行转变期间,更高的病毒传播反而会减少严重的新冠肺炎病例。

Modeling Incorporating the Severity-Reducing Long-term Immunity: Higher Viral Transmission Paradoxically Reduces Severe COVID-19 During Endemic Transition.

作者信息

Hong Hyukpyo, Noh Ji Yun, Lee Hyojung, Choi Sunhwa, Choi Boseung, Kim Jae Kyoung, Shin Eui-Cheol

机构信息

Department of Mathematical Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.

Biomedical Mathematics Group, Institute for Basic Science (IBS), Daejeon 34126, Korea.

出版信息

Immune Netw. 2022 May 18;22(3):e23. doi: 10.4110/in.2022.22.e23. eCollection 2022 Jun.

DOI:10.4110/in.2022.22.e23
PMID:35799710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9250866/
Abstract

Natural infection with severe acute respiratory syndrome-coronavirus-2 or vaccination induces virus-specific immunity protecting hosts from infection and severe disease. While the infection-preventing immunity gradually declines, the severity-reducing immunity is relatively well preserved. Here, based on the different longevity of these distinct immunities, we develop a mathematical model to estimate courses of endemic transition of coronavirus disease 2019 (COVID-19). Our analysis demonstrates that high viral transmission unexpectedly reduces the rates of progression to severe COVID-19 during the course of endemic transition despite increased numbers of infection cases. Our study also shows that high viral transmission amongst populations with high vaccination coverages paradoxically accelerates the endemic transition of COVID-19 with reduced numbers of severe cases. These results provide critical insights for driving public health policies in the era of 'living with COVID-19.'

摘要

严重急性呼吸综合征冠状病毒2的自然感染或疫苗接种可诱导病毒特异性免疫,保护宿主免受感染和重症疾病。虽然预防感染的免疫力会逐渐下降,但减轻疾病严重程度的免疫力相对保持良好。在此,基于这些不同免疫力的不同持久性,我们开发了一个数学模型来估计2019冠状病毒病(COVID-19)的地方病转变过程。我们的分析表明,尽管感染病例数量增加,但在地方病转变过程中,高病毒传播率意外地降低了进展为重症COVID-19的发生率。我们的研究还表明,在高疫苗接种覆盖率人群中,高病毒传播率反而加速了COVID-19的地方病转变,同时重症病例数量减少。这些结果为在“与COVID-19共存”时代推动公共卫生政策提供了关键见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f224/9250866/835b131aa5d7/in-22-e23-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f224/9250866/c9122a6a16f0/in-22-e23-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f224/9250866/d618021886ef/in-22-e23-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f224/9250866/835b131aa5d7/in-22-e23-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f224/9250866/c9122a6a16f0/in-22-e23-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f224/9250866/d618021886ef/in-22-e23-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f224/9250866/835b131aa5d7/in-22-e23-g003.jpg

相似文献

1
Modeling Incorporating the Severity-Reducing Long-term Immunity: Higher Viral Transmission Paradoxically Reduces Severe COVID-19 During Endemic Transition.纳入减轻严重程度的长期免疫力的模型:在流行转变期间,更高的病毒传播反而会减少严重的新冠肺炎病例。
Immune Netw. 2022 May 18;22(3):e23. doi: 10.4110/in.2022.22.e23. eCollection 2022 Jun.
2
The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.SARS-CoV-2 再感染的免疫持久性:一项比较进化研究。
Lancet Microbe. 2021 Dec;2(12):e666-e675. doi: 10.1016/S2666-5247(21)00219-6. Epub 2021 Oct 1.
3
[Immunity to SARS CoV-2 - strengths and weaknesses].[对严重急性呼吸综合征冠状病毒2的免疫——优势与劣势]
Dtsch Med Wochenschr. 2021 Dec;146(24-25):1624-1635. doi: 10.1055/a-1582-2327. Epub 2021 Dec 8.
4
COVID-19 Pandemic-to-Endemic Transition in Indonesia: What Does the Future Hold?印度尼西亚的 COVID-19 大流行向地方病过渡:未来会怎样?
Acta Med Indones. 2022 Apr;54(2):159-160.
5
Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.支持严重急性呼吸综合征冠状病毒 2 在出现症状前或无症状时传播的证据。
Emerg Infect Dis. 2020 Jul;26(7). doi: 10.3201/eid2607.201595. Epub 2020 Jun 21.
6
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
7
Prediction of the Transition From Subexponential to the Exponential Transmission of SARS-CoV-2 in Chennai, India: Epidemic Nowcasting.预测印度钦奈地区 SARS-CoV-2 从亚指数传播向指数传播的转变:疫情实时预测。
JMIR Public Health Surveill. 2020 Sep 18;6(3):e21152. doi: 10.2196/21152.
8
A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)、严重急性呼吸综合征冠状病毒 (SARS-CoV) 和中东呼吸综合征冠状病毒 (MERS-CoV) 的发病机制和宿主固有免疫逃避策略的比较综述。
Arch Microbiol. 2021 Jul;203(5):1943-1951. doi: 10.1007/s00203-021-02265-y. Epub 2021 Mar 7.
9
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
10
Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.纽约市一家大型医疗中心感染严重急性呼吸综合征冠状病毒 2 的母亲所生新生儿的结局。
JAMA Pediatr. 2021 Feb 1;175(2):157-167. doi: 10.1001/jamapediatrics.2020.4298.

引用本文的文献

1
Reflections after 2 years of COVID-19 pandemic.新冠疫情两年后的反思
Rev Med Virol. 2022 Sep;32(5):e2351. doi: 10.1002/rmv.2351. Epub 2022 Apr 5.

本文引用的文献

1
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.奥密克戎变异株对 SARS-CoV-2 表现出明显的抗体逃逸。
Nature. 2022 Feb;602(7898):676-681. doi: 10.1038/s41586-021-04388-0. Epub 2021 Dec 23.
2
Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa.南非新冠病毒奥密克戎变异株(B.1.1.529)与德尔塔变异株相比的相对繁殖数
J Clin Med. 2021 Dec 23;11(1):30. doi: 10.3390/jcm11010030.
3
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
基于信使核糖核酸的新冠病毒疫苗加强针可诱导针对严重急性呼吸综合征冠状病毒2奥密克戎变种的中和免疫力。
Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6.
4
Omicron's feeble attack on the lungs could make it less dangerous.奥密克戎对肺部的攻击较弱,这可能使其危险性降低。
Nature. 2022 Jan;601(7892):177. doi: 10.1038/d41586-022-00007-8.
5
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.莫努匹韦片用于非住院 COVID-19 患者的口服治疗。
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
6
Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.SARS-CoV-2 的奥密克戎和德尔塔变体:刺突蛋白的比较计算研究。
J Med Virol. 2022 Apr;94(4):1641-1649. doi: 10.1002/jmv.27526. Epub 2021 Dec 27.
7
A machine learning model for nowcasting epidemic incidence.用于实时预测疫情发病率的机器学习模型。
Math Biosci. 2022 Jan;343:108677. doi: 10.1016/j.mbs.2021.108677. Epub 2021 Nov 27.
8
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.BNT162b2 mRNA COVID-19 疫苗加强针在预防以色列重症结局的有效性:一项观察性研究。
Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29.
9
Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine.与 SARS-CoV-2 突破性感染相关的时间。
Nat Commun. 2021 Nov 4;12(1):6379. doi: 10.1038/s41467-021-26672-3.
10
Transition to endemicity: Understanding COVID-19.向地方性流行过渡:了解 COVID-19。
Immunity. 2021 Oct 12;54(10):2172-2176. doi: 10.1016/j.immuni.2021.09.019. Epub 2021 Sep 24.